Your browser doesn't support javascript.
loading
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
Szabolcs, Paul; Mazor, Roei D; Yackoubov, Dima; Levy, Stuart; Stiff, Patrick; Rezvani, Andrew; Hanna, Rabi; Wagner, John; Keating, Amy; Lindemans, Caroline A; Karras, Nicole; McGuirk, Joseph; Hamerschlak, Nelson; López-Torija, Ivan; Sanz, Guillermo; Valcarcel, David; Horwitz, Mitchell E.
Afiliación
  • Szabolcs P; Division of Blood and Marrow Transplantation and Cellular Therapy, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
  • Mazor RD; Gamida Cell, Jerusalem, Israel. Electronic address: roeim@gamida-cell.com.
  • Yackoubov D; Gamida Cell, Jerusalem, Israel.
  • Levy S; Gamida Cell, Jerusalem, Israel.
  • Stiff P; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.
  • Rezvani A; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.
  • Hanna R; Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, Ohio.
  • Wagner J; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Keating A; Colorado Children's Hospital, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
  • Lindemans CA; Princes Maxima Children's Hospital and the Department of Pediatrics, University Medical Center, University of Utrecht, Utrecht, The Netherlands.
  • Karras N; Department of Pediatrics City of Hope National Medical Center, Duarte, California.
  • McGuirk J; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, Kansas.
  • Hamerschlak N; Department of Hematology and Bone Marrow Transplantation, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • López-Torija I; Hematology, Oncology and Hematopoietic Transplantation Unit, Pediatric Service. Santa Creu i Sant Pau Hospital, Barcelona, Spain.
  • Sanz G; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Valcarcel D; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Horwitz ME; Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Transplant Cell Ther ; 29(8): 517.e1-517.e12, 2023 08.
Article en En | MEDLINE | ID: mdl-37120136
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Reconstitución Inmune Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Reconstitución Inmune Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article